Navigate to Other Sector



Tags

Healthcare Newsletter – August 2018

RNAi and Gene Therapy - Landmark Approvals, Regulatory Changes & M&A in next genTreatment Options
Burgeoning PE interest in Indian Pharma
Reassuring NCE Interest In Diabetes Despite Escalating Level Of Late Stage Clinical Investments
Regulatory Thrustacross the world in Expedited and Priority Review of Drugs
Out licensing Triumph of Emerging Market Innovation
Continuous Glucose Monitoring Devices Target Greater Value Proposition

Deal Announcement – Series A fund raise for health tech venture HealthSignz
Sathguru Management Consultants Acted As Sole Transaction Advisor To HealthSignz Technologies On Its Equity Fundraise

Sathguru’s healthcare practice lead Pushpa Vijayaraghavan featured in Express Pharma on need to enhance innovation engagement in Indian pharma

Featured Publication
Indian Pharma: Enabling the Transition to Innovation Led Growth
Excerpts from the Assocham Sathguru publication released at the Assocham Pharma Conclave, May 2018

Industry at a Crossover – Quest for Higher Value Generation
– Industry in transition, with rapid shifting of gears in novel chemical and biological entities
– Large pharma companies carving their own niche with some degree of success in specialty Pharma with the 505(b) (2) pathway
– Active engagement in biosimilars for domestic markets, with need to step up pursuit to regulated as well as ROW markets
– Novel vaccines –gradual stepping up to innovation led products with some commercial success
– Robust drug discovery capability in CROs, triggered by rich expertise gained from discovery work for MNCs

Triggering Innovation Leapfrogging – Global Benchmarks
– Indian innovation ecosystem primed from several ends – Ease of access created for seed and early risk funding through TDB & BIRAC i3 Program; Incubation Infrastructure fostered and innovation hubs nurtured; Fiscal incentives such as concessional taxation on royalty income
– International benchmarks for innovation-led growth – Hong Kong, South Korea & Israel

Innovation Led Growth –Recommendations for Leapfrogging Momentum
Need of the hour for next leg of growth include
– Scale-Up Funding and Tech Access Mechanisms
– Strengthening institutional backbone, industry-academia collaboration and IP perception
– Globally comparable fiscal incentives

Click to download the publication


Discussion — No responses

Show Buttons
Hide Buttons